State Street’s Biostage, Inc. Common Stock BSTG Stock Holding History

State Street’s Portfolio BSTG Stock Details BSTG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-84,183	Closed	-$762K	–	3698
2014 Q1	$762K	Buy	84,183 +1,540	+2%	+$9.13K	﹤0.01%	3301
2013 Q4	$392K	Buy	+82,643	New	+$387K	﹤0.01%	3392

Other funds holding BSTG

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAIM

Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

HSA

Hussman Strategic Advisors Ellicott City, Maryland $463M AUM 16% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return

State Street's BSTG Position: Q2 2014 in Review

State Street sold out of Biostage, Inc. Common Stock (BSTG) in Q2 2014, closing a stake of 84,183 shares — an estimated $762K sold.

State Street first reported a position in BSTG in Q4 2013 and held it in 2 quarters. The position peaked at $762K in Q1 2014. 53 funds tracked by Wall St. Rank hold BSTG as of Q2 2014.

State Street reported no remaining Biostage, Inc. Common Stock position as of Q2 2014 after selling out during the quarter.
State Street sold 84,183 Biostage, Inc. Common Stock shares in Q2 2014, an estimated $762K.
State Street first reported a position in Biostage, Inc. Common Stock in Q4 2013 and held it in 2 quarters.
State Street's Biostage, Inc. Common Stock position peaked at $762K in Q1 2014.
53 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q2 2014.

Based on State Street's 13F filing for Q2 2014, filed 12 Aug 2014.